Nebulizer Market By Type, By Product, By Application, By Portability, By End User : Global Opportunity Analysis and Industry Forecast, 2023-2032
세계 네뷸라이저 시장 규모는 2022년 11억 달러에 달했으며, 2023-2032년간 연평균 복합 성장률(CAGR) 7.8%로 성장하여 2032년에는 23억 달러에 달할 것으로 예상됩니다.
네뷸라이저 시장의 성장은 천식, 만성폐쇄성폐질환(COPD), 낭포성 섬유증 등과 같은 호흡기 질환의 유병률 증가로 인해 촉진되고 있습니다. 네뷸라이저는 약물 투여 및 이러한 증상 관리에 일반적으로 사용됩니다. 예를 들어, 2022년 국립 의학 도서관에 따르면 COPD는 전 세계 성인 인구 10명 중 1명이 앓고 있으며, 세계에서 가장 흔한 3대 사망 원인 중 하나라고 보고했습니다. 또한 COPD는 전 세계 건강 격차의 주요 원인이며, 이러한 격차가 극심한 지역일수록 COPD가 더 많이 발생합니다.
또한 전 세계 인구의 고령화가 진행됨에 따라 노인들이 호흡기 질환에 걸리기 쉬워지면서 네뷸라이저를 포함한 호흡기 관리 기기에 대한 수요가 증가하고 있습니다. 또한 많은 도시 지역의 대기 오염 수준이 높아지면서 호흡기 질환의 발생률이 높아지고 있습니다. 네뷸라이저 기술의 발전으로 효율성, 사용 편의성, 휴대성이 향상되어 환자와 의료 서비스 제공업체 모두에게 매력적으로 다가오고 있습니다.
목차
제1장 서론
제2장 주요 요약
제3장 시장 개요
- 시장 정의와 범위
- 주요 조사 결과
- Porter의 Five Forces 분석
- 시장 역학
제4장 네뷸라이저 시장 : 유형별
- 개요
- 제트 네뷸라이저
- 초음파 네뷸라이저
- 메시 네뷸라이저
제5장 네뷸라이저 시장 : 제품별
제6장 네뷸라이저 시장 : 용도별
- 개요
- 만성 폐쇄성 폐질환(COPD)
- 천식
- 기타
제7장 네뷸라이저 시장 : 휴대성별
제8장 네뷸라이저 시장 : 최종사용자별
제9장 네뷸라이저 시장 : 지역별
- 개요
- 북미
- 유럽
- 아시아태평양
- 라틴아메리카/중동 및 아프리카
제10장 경쟁 구도
- 서론
- 주요 성공 전략
- 주요 10개사의 제품 매핑
- 경쟁 대시보드
- 경쟁 히트맵
- 주요 기업의 포지셔닝(2022년)
제11장 기업 개요
- OMRON Healthcare, Inc
- Koninklijke Philips N.V.
- PARI Respiratory Equipment Inc.
- DeVilbiss Healthcare LLC.
- GF Health Products, Inc.
- Trudell Medical International Inc.
- Allied Healthcare Products, Inc.
- Teleflex Incorporated
- Rossmax International Ltd
- Vyaire Medical, Inc.
LSH
According to a new report published by Allied Market Research, titled, "Nebulizer Market," The nebulizer market was valued at $1.1 billion in 2022, and is estimated to reach $2.3 billion by 2032, growing at a CAGR of 7.8% from 2023 to 2032.
The nebulizer market growth is driven by increase in prevalence of respiratory diseases such as
1) asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. Nebulizers are commonly used to administer medication and manage these conditions. For instance, in 2022, according to National Library of Medicine, it was reported that, COPD affects 1 in 10 of the adult global population and is one of the three commonest causes of death worldwide. It is also a major cause of global inequalities in health and is more prevalent where such inequalities are more extreme.
Moreover, as the global population continues to age, there is a growing demand for respiratory care devices, including nebulizers, since older individuals are more susceptible to respiratory conditions. In addition, increase in levels of air pollution in many urban areas have led to a higher incidence of respiratory disorders and advances in nebulizer technology have improved their efficiency, ease of use, and portability, making them more appealing to both patients and healthcare providers.
In addition, a growing trend towards home healthcare and self-management of chronic illnesses has increased the use of nebulizers, as they can be used at home without the need for frequent hospital visits. Along with that Nebulizers are commonly used for children with respiratory issues, as they are effective and less intimidating than other delivery methods. The pediatric nebulizer market is a significant contributor to overall growth.
On the other hand, nebulizer devices, especially newer and more advanced models, can be expensive. This cost can be a barrier to access for some patients, particularly in regions with limited healthcare resources or for individuals with financial constraints. Thus, this factor is anticipated to restrain the growth of the market.
The nebulizer market is segmented into type, product, application, portability, end user, and region. Based on type the market is classified into jet nebulizer, ultrasonic nebulizer, and mesh nebulizer. Based on product, the market is segmented into equipment and accessories. Based on application the market is segmented into COPD, asthma and others. Based on potability, the market is bifurcated into tabletop and portable. Based on end user the market is divided into hospitals, clinics and homecare setting.
Region-wise, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).
Major key players that operate in the global nebulizer market are OMRON Healthcare, Inc, Koninklijke Philips N.V., DeVilbiss Healthcare LLC., GF Health Products, Inc., Trudell Medical International Inc., Allied Healthcare Products, Inc., Teleflex Incorporated, Vyaire Medical, Inc., PARI Respiratory Equipment Inc., and Rossmax International Ltd. Key players operating in the market have adopted product approval, product launch, acquisition, and agreement as their key strategies to expand their nebulizer market share.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the nebulizer market analysis from 2022 to 2032 to identify the prevailing nebulizer market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the nebulizer market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global nebulizer market trends, key players, market segments, application areas, and market growth strategies.
Additional benefits you will get with this purchase are:
- Quarterly Update and* (only available with a corporate license, on listed price)
- 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
- Free Upcoming Version on the Purchase of Five and Enterprise User License.
- 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
- 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
- Free data Pack on the Five and Enterprise User License. (Excel version of the report)
- Free Updated report if the report is 6-12 months old or older.
- 24-hour priority response*
- Free Industry updates and white papers.
Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
- Product Benchmarking / Product specification and applications
- Upcoming/New Entrant by Regions
- New Product Development/ Product Matrix of Key Players
- Patient/epidemiology data at country, region, global level
- Additional company profiles with specific to client's interest
- Additional country or region analysis- market size and forecast
- Expanded list for Company Profiles
- Historic market data
- SWOT Analysis
Key Market Segments
By Type
- Jet nebulizer
- Ultrasonic nebulizer
- Mesh nebulizer
By Product
By Application
By Portability
By End User
- Hospital
- Clinics
- Homecare setting
By Region
- North America
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players:
- DeVilbiss Healthcare LLC.
- Trudell Medical International Inc.
- Allied Healthcare Products, Inc.
- Vyaire Medical, Inc.
- PARI Respiratory Equipment Inc.
- Rossmax International Ltd
- OMRON Healthcare, Inc
- GF Health Products, Inc.
- Teleflex Incorporated
- Koninklijke Philips N.V.
TABLE OF CONTENTS
CHAPTER 1: INTRODUCTION
- 1.1. Report description
- 1.2. Key market segments
- 1.3. Key benefits to the stakeholders
- 1.4. Research methodology
- 1.4.1. Primary research
- 1.4.2. Secondary research
- 1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
- 3.1. Market definition and scope
- 3.2. Key findings
- 3.2.1. Top impacting factors
- 3.2.2. Top investment pockets
- 3.3. Porter's five forces analysis
- 3.3.1. Low bargaining power of suppliers
- 3.3.2. Low threat of new entrants
- 3.3.3. Low threat of substitutes
- 3.3.4. Low intensity of rivalry
- 3.3.5. Low bargaining power of buyers
- 3.4. Market dynamics
- 3.4.1. Drivers
- 3.4.1.1. Rise in prevalence of respiratory diseases.
- 3.4.1.2. Increase in number of geriatric population.
- 3.4.2. Restraints
- 3.4.2.1. Lack of awareness regarding use of nebulizer at homecare setting
- 3.4.3. Opportunities
- 3.4.3.1. Rise in adoption of key strategies by market players
CHAPTER 4: NEBULIZER MARKET, BY TYPE
- 4.1. Overview
- 4.1.1. Market size and forecast
- 4.2. Jet nebulizer
- 4.2.1. Key market trends, growth factors and opportunities
- 4.2.2. Market size and forecast, by region
- 4.2.3. Market share analysis by country
- 4.3. Ultrasonic nebulizer
- 4.3.1. Key market trends, growth factors and opportunities
- 4.3.2. Market size and forecast, by region
- 4.3.3. Market share analysis by country
- 4.4. Mesh nebulizer
- 4.4.1. Key market trends, growth factors and opportunities
- 4.4.2. Market size and forecast, by region
- 4.4.3. Market share analysis by country
CHAPTER 5: NEBULIZER MARKET, BY PRODUCT
- 5.1. Overview
- 5.1.1. Market size and forecast
- 5.2. Equipment
- 5.2.1. Key market trends, growth factors and opportunities
- 5.2.2. Market size and forecast, by region
- 5.2.3. Market share analysis by country
- 5.3. Accessories
- 5.3.1. Key market trends, growth factors and opportunities
- 5.3.2. Market size and forecast, by region
- 5.3.3. Market share analysis by country
CHAPTER 6: NEBULIZER MARKET, BY APPLICATION
- 6.1. Overview
- 6.1.1. Market size and forecast
- 6.2. COPD
- 6.2.1. Key market trends, growth factors and opportunities
- 6.2.2. Market size and forecast, by region
- 6.2.3. Market share analysis by country
- 6.3. Asthma
- 6.3.1. Key market trends, growth factors and opportunities
- 6.3.2. Market size and forecast, by region
- 6.3.3. Market share analysis by country
- 6.4. Others
- 6.4.1. Key market trends, growth factors and opportunities
- 6.4.2. Market size and forecast, by region
- 6.4.3. Market share analysis by country
CHAPTER 7: NEBULIZER MARKET, BY PORTABILITY
- 7.1. Overview
- 7.1.1. Market size and forecast
- 7.2. Tabletop
- 7.2.1. Key market trends, growth factors and opportunities
- 7.2.2. Market size and forecast, by region
- 7.2.3. Market share analysis by country
- 7.3. Portable
- 7.3.1. Key market trends, growth factors and opportunities
- 7.3.2. Market size and forecast, by region
- 7.3.3. Market share analysis by country
CHAPTER 8: NEBULIZER MARKET, BY END USER
- 8.1. Overview
- 8.1.1. Market size and forecast
- 8.2. Hospital
- 8.2.1. Key market trends, growth factors and opportunities
- 8.2.2. Market size and forecast, by region
- 8.2.3. Market share analysis by country
- 8.3. Clinics
- 8.3.1. Key market trends, growth factors and opportunities
- 8.3.2. Market size and forecast, by region
- 8.3.3. Market share analysis by country
- 8.4. Homecare setting
- 8.4.1. Key market trends, growth factors and opportunities
- 8.4.2. Market size and forecast, by region
- 8.4.3. Market share analysis by country
CHAPTER 9: NEBULIZER MARKET, BY REGION
- 9.1. Overview
- 9.1.1. Market size and forecast By Region
- 9.2. North America
- 9.2.1. Key market trends, growth factors and opportunities
- 9.2.2. Market size and forecast, by Type
- 9.2.3. Market size and forecast, by Product
- 9.2.4. Market size and forecast, by Application
- 9.2.5. Market size and forecast, by Portability
- 9.2.6. Market size and forecast, by End User
- 9.2.7. Market size and forecast, by country
- 9.2.7.1. U.S.
- 9.2.7.1.1. Market size and forecast, by Type
- 9.2.7.1.2. Market size and forecast, by Product
- 9.2.7.1.3. Market size and forecast, by Application
- 9.2.7.1.4. Market size and forecast, by Portability
- 9.2.7.1.5. Market size and forecast, by End User
- 9.2.7.2. Canada
- 9.2.7.2.1. Market size and forecast, by Type
- 9.2.7.2.2. Market size and forecast, by Product
- 9.2.7.2.3. Market size and forecast, by Application
- 9.2.7.2.4. Market size and forecast, by Portability
- 9.2.7.2.5. Market size and forecast, by End User
- 9.2.7.3. Mexico
- 9.2.7.3.1. Market size and forecast, by Type
- 9.2.7.3.2. Market size and forecast, by Product
- 9.2.7.3.3. Market size and forecast, by Application
- 9.2.7.3.4. Market size and forecast, by Portability
- 9.2.7.3.5. Market size and forecast, by End User
- 9.3. Europe
- 9.3.1. Key market trends, growth factors and opportunities
- 9.3.2. Market size and forecast, by Type
- 9.3.3. Market size and forecast, by Product
- 9.3.4. Market size and forecast, by Application
- 9.3.5. Market size and forecast, by Portability
- 9.3.6. Market size and forecast, by End User
- 9.3.7. Market size and forecast, by country
- 9.3.7.1. Germany
- 9.3.7.1.1. Market size and forecast, by Type
- 9.3.7.1.2. Market size and forecast, by Product
- 9.3.7.1.3. Market size and forecast, by Application
- 9.3.7.1.4. Market size and forecast, by Portability
- 9.3.7.1.5. Market size and forecast, by End User
- 9.3.7.2. France
- 9.3.7.2.1. Market size and forecast, by Type
- 9.3.7.2.2. Market size and forecast, by Product
- 9.3.7.2.3. Market size and forecast, by Application
- 9.3.7.2.4. Market size and forecast, by Portability
- 9.3.7.2.5. Market size and forecast, by End User
- 9.3.7.3. UK
- 9.3.7.3.1. Market size and forecast, by Type
- 9.3.7.3.2. Market size and forecast, by Product
- 9.3.7.3.3. Market size and forecast, by Application
- 9.3.7.3.4. Market size and forecast, by Portability
- 9.3.7.3.5. Market size and forecast, by End User
- 9.3.7.4. Italy
- 9.3.7.4.1. Market size and forecast, by Type
- 9.3.7.4.2. Market size and forecast, by Product
- 9.3.7.4.3. Market size and forecast, by Application
- 9.3.7.4.4. Market size and forecast, by Portability
- 9.3.7.4.5. Market size and forecast, by End User
- 9.3.7.5. Spain
- 9.3.7.5.1. Market size and forecast, by Type
- 9.3.7.5.2. Market size and forecast, by Product
- 9.3.7.5.3. Market size and forecast, by Application
- 9.3.7.5.4. Market size and forecast, by Portability
- 9.3.7.5.5. Market size and forecast, by End User
- 9.3.7.6. Rest of Europe
- 9.3.7.6.1. Market size and forecast, by Type
- 9.3.7.6.2. Market size and forecast, by Product
- 9.3.7.6.3. Market size and forecast, by Application
- 9.3.7.6.4. Market size and forecast, by Portability
- 9.3.7.6.5. Market size and forecast, by End User
- 9.4. Asia-Pacific
- 9.4.1. Key market trends, growth factors and opportunities
- 9.4.2. Market size and forecast, by Type
- 9.4.3. Market size and forecast, by Product
- 9.4.4. Market size and forecast, by Application
- 9.4.5. Market size and forecast, by Portability
- 9.4.6. Market size and forecast, by End User
- 9.4.7. Market size and forecast, by country
- 9.4.7.1. Japan
- 9.4.7.1.1. Market size and forecast, by Type
- 9.4.7.1.2. Market size and forecast, by Product
- 9.4.7.1.3. Market size and forecast, by Application
- 9.4.7.1.4. Market size and forecast, by Portability
- 9.4.7.1.5. Market size and forecast, by End User
- 9.4.7.2. China
- 9.4.7.2.1. Market size and forecast, by Type
- 9.4.7.2.2. Market size and forecast, by Product
- 9.4.7.2.3. Market size and forecast, by Application
- 9.4.7.2.4. Market size and forecast, by Portability
- 9.4.7.2.5. Market size and forecast, by End User
- 9.4.7.3. India
- 9.4.7.3.1. Market size and forecast, by Type
- 9.4.7.3.2. Market size and forecast, by Product
- 9.4.7.3.3. Market size and forecast, by Application
- 9.4.7.3.4. Market size and forecast, by Portability
- 9.4.7.3.5. Market size and forecast, by End User
- 9.4.7.4. Australia
- 9.4.7.4.1. Market size and forecast, by Type
- 9.4.7.4.2. Market size and forecast, by Product
- 9.4.7.4.3. Market size and forecast, by Application
- 9.4.7.4.4. Market size and forecast, by Portability
- 9.4.7.4.5. Market size and forecast, by End User
- 9.4.7.5. South Korea
- 9.4.7.5.1. Market size and forecast, by Type
- 9.4.7.5.2. Market size and forecast, by Product
- 9.4.7.5.3. Market size and forecast, by Application
- 9.4.7.5.4. Market size and forecast, by Portability
- 9.4.7.5.5. Market size and forecast, by End User
- 9.4.7.6. Rest of Asia-Pacific
- 9.4.7.6.1. Market size and forecast, by Type
- 9.4.7.6.2. Market size and forecast, by Product
- 9.4.7.6.3. Market size and forecast, by Application
- 9.4.7.6.4. Market size and forecast, by Portability
- 9.4.7.6.5. Market size and forecast, by End User
- 9.5. LAMEA
- 9.5.1. Key market trends, growth factors and opportunities
- 9.5.2. Market size and forecast, by Type
- 9.5.3. Market size and forecast, by Product
- 9.5.4. Market size and forecast, by Application
- 9.5.5. Market size and forecast, by Portability
- 9.5.6. Market size and forecast, by End User
- 9.5.7. Market size and forecast, by country
- 9.5.7.1. Brazil
- 9.5.7.1.1. Market size and forecast, by Type
- 9.5.7.1.2. Market size and forecast, by Product
- 9.5.7.1.3. Market size and forecast, by Application
- 9.5.7.1.4. Market size and forecast, by Portability
- 9.5.7.1.5. Market size and forecast, by End User
- 9.5.7.2. Saudi Arabia
- 9.5.7.2.1. Market size and forecast, by Type
- 9.5.7.2.2. Market size and forecast, by Product
- 9.5.7.2.3. Market size and forecast, by Application
- 9.5.7.2.4. Market size and forecast, by Portability
- 9.5.7.2.5. Market size and forecast, by End User
- 9.5.7.3. South Africa
- 9.5.7.3.1. Market size and forecast, by Type
- 9.5.7.3.2. Market size and forecast, by Product
- 9.5.7.3.3. Market size and forecast, by Application
- 9.5.7.3.4. Market size and forecast, by Portability
- 9.5.7.3.5. Market size and forecast, by End User
- 9.5.7.4. Rest of LAMEA
- 9.5.7.4.1. Market size and forecast, by Type
- 9.5.7.4.2. Market size and forecast, by Product
- 9.5.7.4.3. Market size and forecast, by Application
- 9.5.7.4.4. Market size and forecast, by Portability
- 9.5.7.4.5. Market size and forecast, by End User
CHAPTER 10: COMPETITIVE LANDSCAPE
- 10.1. Introduction
- 10.2. Top winning strategies
- 10.3. Product mapping of top 10 player
- 10.4. Competitive dashboard
- 10.5. Competitive heatmap
- 10.6. Top player positioning, 2022
CHAPTER 11: COMPANY PROFILES
- 11.1. OMRON Healthcare, Inc
- 11.1.1. Company overview
- 11.1.2. Key executives
- 11.1.3. Company snapshot
- 11.1.4. Operating business segments
- 11.1.5. Product portfolio
- 11.1.6. Business performance
- 11.2. Koninklijke Philips N.V.
- 11.2.1. Company overview
- 11.2.2. Key executives
- 11.2.3. Company snapshot
- 11.2.4. Operating business segments
- 11.2.5. Product portfolio
- 11.2.6. Business performance
- 11.3. PARI Respiratory Equipment Inc.
- 11.3.1. Company overview
- 11.3.2. Key executives
- 11.3.3. Company snapshot
- 11.3.4. Operating business segments
- 11.3.5. Product portfolio
- 11.3.6. Key strategic moves and developments
- 11.4. DeVilbiss Healthcare LLC.
- 11.4.1. Company overview
- 11.4.2. Key executives
- 11.4.3. Company snapshot
- 11.4.4. Operating business segments
- 11.4.5. Product portfolio
- 11.5. GF Health Products, Inc.
- 11.5.1. Company overview
- 11.5.2. Key executives
- 11.5.3. Company snapshot
- 11.5.4. Operating business segments
- 11.5.5. Product portfolio
- 11.6. Trudell Medical International Inc.
- 11.6.1. Company overview
- 11.6.2. Key executives
- 11.6.3. Company snapshot
- 11.6.4. Operating business segments
- 11.6.5. Product portfolio
- 11.7. Allied Healthcare Products, Inc.
- 11.7.1. Company overview
- 11.7.2. Key executives
- 11.7.3. Company snapshot
- 11.7.4. Operating business segments
- 11.7.5. Product portfolio
- 11.7.6. Business performance
- 11.8. Teleflex Incorporated
- 11.8.1. Company overview
- 11.8.2. Key executives
- 11.8.3. Company snapshot
- 11.8.4. Operating business segments
- 11.8.5. Product portfolio
- 11.8.6. Business performance
- 11.9. Rossmax International Ltd
- 11.9.1. Company overview
- 11.9.2. Key executives
- 11.9.3. Company snapshot
- 11.9.4. Operating business segments
- 11.9.5. Product portfolio
- 11.9.6. Key strategic moves and developments
- 11.10. Vyaire Medical, Inc.
- 11.10.1. Company overview
- 11.10.2. Key executives
- 11.10.3. Company snapshot
- 11.10.4. Operating business segments
- 11.10.5. Product portfolio
